Estrella doses first patient in EB103 trial expansion phase
Estrella doses first patient in EB103 trial expansion phase
Estrella doses first patient in EB103 trial expansion phase
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.